Increased expression of IL-17A has been linked to inflammatory diseases such as asthma, cystic fibrosis, and COPD in the airway, as well as inflammatory bowel disease, and it appears to play an important protective role against infection [41,42,43]. This evidence concerns the gene IL17A and cystic fibrosis.